Can a virtual community curb Opioid-Linked HIV and hepatitis c in rural america?
NCT ID NCT05363865
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a digital, community-led program to help people in rural Appalachia and the Midwest reduce their risk of HIV and hepatitis C, often linked to opioid use. Over 500 adults took part, with half currently or previously using illicit substances. The program included online modules on prevention, stigma, and mental health, plus standard health information. Researchers measured whether participants got tested, learned their status, started treatment, and adopted safer behaviors.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Virtual community intervention (behavioral)
What this could lead to
If successful, this approach could help reduce HIV and hepatitis C infections in rural areas by encouraging testing, treatment, and safer practices.
What could go wrong
This is a completed behavioral study, not a drug trial. Results may not apply to other regions or populations, and self-reported outcomes can be unreliable.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Pennsylvania
Philadelphia, Pennsylvania, 19103, United States